Studies directed toward the design of orally active renin inhibitors. 1. Some factors influencing the absorption of small peptides.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1993-02-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00056A005PMID 8474101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties.

  1992cited by this paper
• Oral Delivery of a Renin Inhibitor Compound Using Emulsion Formulations

  1992cited by this paper
• Highly potent, orally active diester macrocyclic human renin inhibitors.

  1992cited by this paper
• Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy.

  1992cited by this paper
• 1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors.

  1992cited by this paper
• Effect of the Renin Response During Renin Inhibition: Oral Ro 42–5892 in Normal Humans

  1991cited by this paper
• Ro 42‐5892 Is a Potent Orally Active Renin Inhibitor in Primates

  1991cited by this paper
• Design of a well-absorbed renin inhibitor.

  1991cited by this paper
• Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties.

  1991cited by this paper
• 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives.

  1990cited by this paper
• Pharmacokinetics and tissue distribution of the renin inhibitor N-(2-(R)-benzyl-3-tert-butyl-sulfonyl-propionyl)-His-ChacVal-n-butylami ne in marmosets.

  1990cited by this paper
• Design and discovery in the development of long-acting renin inhibitors.

  1990cited by this paper
• Renin inhibitors.

  1990cited by this paper
• Water-soluble renin inhibitors: design of a subnanomolar inhibitor with a prolonged duration of action.

  1990cited by this paper
• Potent, low molecular weight renin inhibitors containing a C-terminal heterocycle: hydrogen bonding at the active site.

  1990cited by this paper
• Azido glycols: potent, low molecular weight renin inhibitors containing an unusual post scissile site residue.

  1989cited by this paper
• Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.

  1989cited by this paper
• A novel nonpeptidic, orally active renin inhibitor.

  1989cited by this paper
• Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.

  1988cited by this paper
• Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.

  1988cited by this paper
• Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.

  1987cited by this paper
• Studies on polypeptides. XL. Synthetic routes to peptides containing beta-(pyrazolyl-1)-and beta-(pyrazolyl-3)-alanine.

  1968cited by this paper
• On the size of the active site in proteases. I. Papain.

  1967cited by this paper
• Studies on polypeptides. XXXVI. The effect of pyrazole-imidazole replacements on the S-protein activating potency of an S-peptide fragment.

  1966cited by this paper
• SOME PHYSICO‐CHEMICAL FACTORS IN DRUG ACTION

  1957cited by this paper

• Green synthesis and properties of arginine derived complexes for assorted drug delivery systems: A review

  2021cites this paper
• Synthesis and Investigation of Pinane-Based Chiral Tridentate Ligands in the Asymmetric Addition of Diethylzinc to Aldehydes

  2020cites this paper
• Deoxyalkoxyamination of Alcohols for the Synthesis of N -Alkoxy-N -alkylbenzenesulfonamides

  2018cites this paper
• Optimized syntheses of Fmoc azido amino acids for the preparation of azidopeptides

  2017cites this paper
• Unusual Amino Acids in Medicinal Chemistry.

  2016cites this paper
• Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.

  2012cites this paper
• Regioselective inversion of the hydroxyl group in D-ribo-phytosphingosine via a cyclic sulfate and bis-sulfonate intermediate.

  2011cites this paper
• Evolution of Diverse Classes of Renin Inhibitors through the Years

  2011cites this paper
• Antihypertensives: Renin Inhibitors

  2010cites this paper
• The roles of structural variability and amphiphilicity of TMC278/rilpivirine in mechanisms of HIV drug resistance avoidance and enhanced oral bioavailability

  2009cites this paper
• Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.

  2009cites this paper
• Lipophilicity in Peptide Chemistry and Peptide Drug Design

  2008cites this paper
• Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability.

  2005cites this paper
• Novel RGD-like molecules based on the tyrosine template: design, synthesis, and biological evaluation on isolated integrins alphaVbeta3/alphaIIbbeta3 and in cellular adhesion tests.

  2004cites this paper
• Synthesis of heterocycles from alkyl 3-(dimethylamino)propenoates and related enaminones.

  2004cites this paper
• Expedient synthesis of triazole-linked glycosyl amino acids and peptides.

  2004cites this paper
• High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.

  2001cites this paper
• Peroral route: an opportunity for protein and peptide drug delivery.

  2001cites this paper
• N‐Benzyloxycarbonyl‐L‐serine β‐Lactone

  2001cites this paper
• High-throughput screening approaches for investigating drug metabolism and pharmacokinetics

  2001cites this paper
• Acyclic Oxyiminium Ions. Mannich Reactions and Addition of Grignard Reagents

  2000cites this paper
• High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.

  2000cites this paper
• Stereoselective synthesis of renin inhibitor BILA 2157 BS

  2000cites this paper
• Practical Synthesis of BILA 2157 BS, a Potent and Orally Active Renin Inhibitor: Use of an Enzyme-Catalyzed Hydrolysis for the Preparation of Homochiral Succinic Acid Derivatives.

  1999cites this paper
• Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age.

  1999cites this paper
• Oxidative ring‐opening of rel‐(2R,3R,5S)‐5‐aryl‐2‐benzoylamino‐6,7‐bis(methoxycarbonyl)‐2,3‐dihydro‐1‐oxo‐3‐phenyl‐1H,5H‐pyrazolo[1,2‐a]‐pyrazoles. Synthesis of rel‐(2R,3R)‐3‐phenyl‐3‐[5‐aryl‐3,4‐bis(methoxycarbonyl)pyrazolyl‐1]alanine esters

  1999cites this paper
• Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy.

  1999cites this paper
• Renin inhibitors.

  1998cites this paper
• Chemical Approaches to Improve the Oral Bioavailability of Peptidergic Molecules

  1996cites this paper
• Synthetic library techniques: Subjective (biased and generic) thoughts and views

  1996cites this paper
• Selective Inversion of the Proximal or Distal Hydroxyl Groups in syn,syn-3-[N-(Alkoxycarbonyl)amino] 1,2-Diols via Cyclic Sulfates.

  1996cites this paper
• Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics

  1996cites this paper
• Renin inhibition: a novel therapy for cardiovascular disease.

  1996cites this paper
• Lead development: validation and application of high throughput screening for determination of pharmacokinetic parameters for enzyme inhibitors.

  1996cites this paper
• An Efficient Process for the Synthesis of Renin Inhibitor, ABT-517

  1996cites this paper
• Optimization of Peptide Leads and Molecular Modeling

  1995cites this paper
• Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombin.

  1995cites this paper
• Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word?

  1995cites this paper
• alpha-Hydroxy phosphinyl-based inhibitors of human renin.

  1995cites this paper
• Progress in the discovery of orally bioavailable inhibitors of HIV protease

  1995cites this paper
• 2 Renin Inhibitors

  1995cites this paper
• Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dog.

  1994cites this paper
• CASE HISTORIES OF PEPTIDOMIMETICS : PROGRESSION FROM PEPTIDES TO DRUGS

  1994cites this paper
• Design of drugs through a consideration of drug metabolism and pharmacokinetics

  1994cites this paper
• Synthesis, antiviral activity, and bioavailability studies of gamma-lactam derived HIV protease inhibitors.

  1994cites this paper
• Renin Inhibitor: Relationship Between Molecular Structure and Oral Absorption

  1994cites this paper
• Reaction of trimethylsilylamines with N-Cbz-L-serine-β-lactone: A convenient route to optically pure β-amino-L-alanine derivatives

  1994cites this paper
• Synthesis and structural studies of asparagine-modified 2-deoxy-alpha-N-glycopeptides associated with the renin-angiotensin system.

  1994cites this paper
• Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.

  1994cites this paper
• Appraisal of a glycopeptide cloaking strategy for a therapeutic oligopeptide: glycopeptide analogs of the renin inhibitor ditekiren.

  1994cites this paper
• Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketones.

  1994cites this paper
• Renin inhibitors: C-terminal oxetanes as potent transition-state mimics.

  1994cites this paper
• Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors.

  1994cites this paper
• Overview Cardiovascular & Renal: Recent developments in renin inhibitors: part 1

  1994cites this paper
• Synthesis and structural studies of asparagine-modified 2-deoxy-α-N-glycopeptides associated with the renin-Angiotensin system

  1994cites this paper
• The identification of a novel renin inhibitor of equivalent efficacy following oral or intravenous administration.

  1994cites this paper
• (Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists.

  1993cites this paper